Patents by Inventor Neerav D. Padliya

Neerav D. Padliya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR PRODUCING NON-HUMAN TISSUE ENGINEERED MEAT PRODUCTS
    Publication number: 20240156137
    Abstract: Methods for producing a non-human meat products in a culture media containing egg yolk powder and culture media containing egg yolk powder are provided.
    Type: Application
    Filed: November 6, 2023
    Publication date: May 16, 2024
    Inventors: Joseph MANNELLO, Neerav D. PADLIYA
  • MUSCLE ENHANCING PRODUCTS
    Publication number: 20240099342
    Abstract: Composition containing egg yolk powder and a second muscle enhancing product for use in enhancing muscle growth and slowing muscle degeneration in mammals are provided. Embodiments of the present invention are generally related to muscle enhancing products. More specifically, embodiments of the present invention relate to egg-based products in combination with one or more muscle enhancing products, and methods of manufacturing and use of the same.
    Type: Application
    Filed: October 29, 2020
    Publication date: March 28, 2024
    Inventors: Neerav D. PADLIYA, Maghsoud DARIANI
  • Methods and Compositions for Improving Quality of Life and Increasing Activity in Aging and Chronically Ill Mammals
    Publication number: 20240050519
    Abstract: Methods for improving quality of life and/or increasing activity in an aging and/or chronically ill mammal via administration of a composition of egg powder protein are provided.
    Type: Application
    Filed: October 25, 2023
    Publication date: February 15, 2024
    Inventors: Joseph MANNELLO, Maghsoud DARIANI, Neerav D. PADLIYA
  • Methods and compositions for improving quality of life and increasing activity in aging and chronically ill mammals
    Patent number: 11833186
    Abstract: Methods for improving quality of life and/or increasing activity in an aging and/or chronically ill mammal via administration of a composition of egg powder protein are provided.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: December 5, 2023
    Assignee: MYOS CORP.
    Inventors: Joseph Mannello, Maghsoud Dariani, Neerav D. Padliya
  • METHODS AND COMPOSITIONS FOR ENHANCING OVERALL HEALTH AND LONGEVITY IN MAMMALS
    Publication number: 20220370511
    Abstract: Compositions containing egg yolk powder and a NAD+ precursor and/or pterostilbene and/or an agent promoting mitochondrial rejuvenation for use in enhancing overall health and longevity in mammals are provided.
    Type: Application
    Filed: November 5, 2020
    Publication date: November 24, 2022
    Inventors: Neerav D. PADLIYA, Maghsoud DARIANI
  • Methods and compositions for improving skeletal muscle protein fractional synthetic rate
    Patent number: 11318171
    Abstract: Methods and egg yolk powder containing compositions for improving skeletal muscle protein fractional synthetic rate (FSR) in mammals and inhibiting or reversing sarcopenia are provided.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: May 3, 2022
    Assignee: MYOS CORP.
    Inventors: Joseph Mannello, Neerav D. Padliya, Maghsoud Dariani
  • METHODS FOR ALLEVIATING POST-POLIO MUSCLE WEAKNESS AND CONDITIONS SIMILAR THERETO
    Publication number: 20210379117
    Abstract: Methods for alleviating, reversing or inhibiting one or more symptom of post-polio syndrome via administration of a composition comprising egg yolk powder are provided.
    Type: Application
    Filed: June 4, 2021
    Publication date: December 9, 2021
    Inventors: Joseph MANNELLO, Maghsoud DARIANI, Neerav D. PADLIYA
  • Methods and compositions for improving skeletal muscle protein fractional synthetic rate
    Patent number: 10925904
    Abstract: Methods and egg yolk powder containing compositions for improving skeletal muscle protein fractional synthetic rate (FSR) in mammals and inhibiting or reversing sarcopenia are provided.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: February 23, 2021
    Assignee: MYOS RENS TECHNOLOGY, INC.
    Inventors: Joseph Mannello, Neerav D. Padliya, Maghsoud Dariani
  • Methods and Compositions for Improving Quality of Life and Increasing Activity in Aging and Chronically Ill Mammals
    Publication number: 20210030840
    Abstract: Methods for improving quality of life and/or increasing activity in an aging and/or chronically ill mammal via administration of a composition of egg yolk powder are provided. In some embodiments, additional agents improving quality of life and/or increasing activity in an aging and/or chronically ill mammal are administered in combination with the egg yolk powder.
    Type: Application
    Filed: October 7, 2020
    Publication date: February 4, 2021
    Inventors: Joseph MANNELLO, Maghsoud DARIANI, Neerav D. PADLIYA
  • METHODS AND COMPOSITIONS FOR IMPROVING SKELETAL MUSCLE PROTEIN FRACTIONAL SYNTHETIC RATE
    Publication number: 20200276247
    Abstract: Methods and egg yolk powder containing compositions for improving skeletal muscle protein fractional synthetic rate (FSR) in mammals and inhibiting or reversing sarcopenia are provided.
    Type: Application
    Filed: May 18, 2020
    Publication date: September 3, 2020
    Inventors: Joseph MANNELLO, Neerav D. PADLIYA, Maghsoud DARIANI
  • Methods and Compositions for Improving Quality of Life and Increasing Activity in Aging and Chronically Ill Mammals
    Publication number: 20200246422
    Abstract: Methods for improving quality of life and/or increasing activity in an aging and/or chronically ill mammal via administration of a composition of egg powder protein are provided.
    Type: Application
    Filed: January 29, 2020
    Publication date: August 6, 2020
    Inventors: Joseph MANNELLO, Maghsoud DARIANI, Neerav D. PADLIYA
  • METHODS AND COMPOSITIONS FOR IMPROVING SKELETAL MUSCLE PROTEIN FRACTIONAL SYNTHETIC RATE
    Publication number: 20200138873
    Abstract: Methods and egg yolk powder containing compositions for improving skeletal muscle protein fractional synthetic rate (FSR) in mammals and inhibiting or reversing sarcopenia are provided.
    Type: Application
    Filed: July 11, 2019
    Publication date: May 7, 2020
    Inventors: Joseph MANNELLO, Neerav D. PADLIYA, Maghsoud DARIANI
  • ANGIOGENESIS USING PLACENTAL STEM CELLS
    Publication number: 20160106784
    Abstract: Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
    Type: Application
    Filed: December 22, 2015
    Publication date: April 21, 2016
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Robert J. Hariri, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Neerav D. Padliya, Jennifer Paredes, Jia-Lun Wang
  • Angiogenesis using placental stem cells
    Patent number: 9254302
    Abstract: Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: February 9, 2016
    Assignee: ANTHROGENESIS CORPORATION
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Robert J. Hariri, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Neerav D. Padliya, Jennifer Paredes, Jia-Lun Wang
  • Amnion derived adherent cells
    Patent number: 8367409
    Abstract: Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.
    Type: Grant
    Filed: November 19, 2009
    Date of Patent: February 5, 2013
    Assignee: Anthrogenesis Corporation
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Aleksandr Kaplunovsky, Vladimir Jankovic, Kristen Labazzo, Eric Law, Neerav D. Padliya, Jennifer Paredes, Jia-Lun Wang
  • ANGIOGENESIS USING PLACENTAL STEM CELLS
    Publication number: 20110250182
    Abstract: Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
    Type: Application
    Filed: April 6, 2011
    Publication date: October 13, 2011
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Stewart ABBOT, James W. EDINGER, Aleksandar FRANCKI, Robert J. HARIRI, Vladimir JANKOVIC, Aleksandr KAPLUNOVSKY, Kristen LABAZZO, Eric LAW, Neerav D. PADLIYA, Jennifer PAREDES, Jia-Lun WANG
  • AMNION DERIVED ADHERENT CELLS
    Publication number: 20100124569
    Abstract: Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.
    Type: Application
    Filed: November 19, 2009
    Publication date: May 20, 2010
    Inventors: Stewart ABBOT, James W. Edinger, Aleksandar Francki, Aleksandr Kaplunovsky, Vladimir Jankovic, Kristen Labazzo, Eric Law, Neerav D. Padliya, Jennifer Paredes, Jia-Lun Wang